Thalidomide in the treatment of multiple myeloma
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference98 articles.
1. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;The New England Journal of Medicine,1999
2. Clinical pharmacokinetics of thalidomide;Teo;Clinical Pharmacokinetics,2004
3. Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis;Eriksson;The Journal of Pharmacy and Pharmacology,2003
4. Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent;Bauer;Biochemical Pharmacology,1998
5. Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women;Teo;Biopharmaceutics & Drug Disposition,2000
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review;Ibrain;2022-12-22
2. The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma;OncoImmunology;2018-08
3. Impact of pomalidomide therapy in multiple myeloma: a recent survey;Journal of Chemotherapy;2014-07-09
4. Role of thalidomide in the treatment of patients with multiple myeloma;Critical Reviews in Oncology/Hematology;2013-10
5. Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens;American Journal of Hematology;2013-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3